Skip to content Skip to footer

International Cannabis Weekly: 280

January 6, 2023

Highlights

Share this story

THE FDA TO MAKE RECOMMENDATIONS ON REGULATION OF CANNABIS-DERIVED PRODUCTS IN THE COMING MONTHS

The FDA is studying whether legal cannabis is safe in food or supplements and plans to make recommendations for how to regulate the growing number of cannabis-derived products in the coming months, writes the Wall Street Journal.

The head of the FDA’s office for developing cannabis strategy, Patrick Cournoyer, said the agency is aiming to find out if CBD can be safely eaten every day for a long period or during pregnancy. The FDA will then decide ‘within months’ how legal cannabis should best be regulated.

READ MORE »

WHAT IS IN STORE FOR THE EUROPEAN CANNABIS INDUSTRY IN 2023?

READ MORE »

CONNECTICUT CLEARS RECORDS OF NEARLY 43,000 CANNABIS CONVICTIONS

READ MORE »

Highlights

Share this story
Europe
  • The Swiss federal commission on addiction issues advocates for legal and controlled access to cannabis products.
  • Lithuanian President Gitanas Nausėda opposes decriminalisation of cannabis in the country.
  • Survey finds that 66% of the Czech Republic support cannabis legalisation while 76% are open to regulated sales.
  • Spain’s Agency for Medicines and Health Products to release plans by the end of January for legalisation.
  • Celadon Pharmaceuticals is confident in the UK regulatory approval for its’ cannabis medicine facility.
  • Italian soldiers producing own-brand cannabis to meet demand for legal medical market in Italy.
  • New study finds cannabis-based medicinal products effective in improving symptoms of PTSD, sleep and anxiety.
  • Luxembourg’s attorney general’s office has addressed concerns about the legalisation of recreational cannabis.
  • Synthetic cannabinoids: Analytical methodology for detection in illegal street drugs and medical cannabis products.
  • Irish government urged to consider cannabis legalisation for adult use and drug policy reforms.

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Upcoming Event

SECURE YOUR CANNABIS EUROPA TICKETS TODAY

This May 2-3, Cannabis Europa returns to the Barbican Centre. Join us for two days of exceptional networking opportunities, industry defining discussions with genuine decision makers and future predictions for the growing European cannabis industry.
This year you have a chance to amplify your presence in London by joining us at Cannabis Europa.

SECURE YOUR SEAT »

SECURE YOUR VIP SEAT (ONLY 99 AVAILABLE) »

Highlights

Share this story
Canada
  • Flora Growth closes acquisition of Franchise Global Health, cementing foothold in Germany and EU.
  • Quebec’s cannabis laws, which mean consumers are limited to certain products, are helping the black market thrive.
  • Annual Canadian Cannabis Survey finds stable cannabis use rates, increasing legal dispensary usage.
  • Health Canada announces approval of amendments to regulations concerning cannabis research, testing and beverages.
  • A new study finds medical cannabis reform in Canada to be associated with reduced alcohol sales.

Highlights

Share this story
New Report

To complement the Global Cannabis Report: 3rd Edition, we have two premium packages available.

The first is Prohibition Partners’ proprietary market sizing data, which includes country-by-country forecasts of the medical, CBD and adult-use cannabis markets around the globe.

The second package is Prohibition Partners’ proprietary market sizing data, as well as a comprehensive collection of real world data, showing the growth in sales of cannabis globally.

BUY THE DATA PACKAGES »

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East

 

Latest Issues

283

282

281

280

279

278

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.